JBIO
Jade Biosciences, Inc.
Company overview
- Market capitalization
- $912.62M
- Employees
- 55
- Latest publication
- 2026-09-29
About Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 9,000USD | 9,000USD | 12,000USD | 1,000USD | 4,000USD | 8,000USD | 218,000USD | 28,000USD |
| Gross Profit | -9,000USD | -9,000USD | -12,000USD | -1,000USD | -4,000USD | -8,000USD | -218,000USD | -28,000USD |
| Research Development | 36,053,000USD | 28,541,000USD | 22,010,000USD | 22,547,000USD | 20,023,000USD | 1,531,000USD | 13,581,000USD | 21,248,000USD |
| Selling General Administrative | 7,392,000USD | 6,438,000USD | 5,391,000USD | 5,231,000USD | 3,361,000USD | 2,408,000USD | 1,896,000USD | — |
| Total Operating Expenses | 43,436,000USD | 34,979,000USD | 27,401,000USD | 27,778,000USD | 3,383,000USD | 6,395,000USD | 14,965,000USD | 26,137,000USD |
| Operating Income | -43,445,000USD | -34,979,000USD | -27,401,000USD | -27,778,000USD | -3,387,000USD | -6,403,000USD | -14,965,000USD | -26,165,000USD |
| Interest Income | 3,102,000USD | 3,085,000USD | 2,254,000USD | 1,828,000USD | 615,000USD | 771,000USD | 388,000USD | — |
| Net Interest Income | 3,102,000USD | 3,085,000USD | 2,254,000USD | 1,828,000USD | 615,000USD | 771,000USD | 388,000USD | — |
| Income Before Tax | -40,352,000USD | -31,874,000USD | -25,175,000USD | -32,134,000USD | -2,518,000USD | -5,375,000USD | -16,277,000USD | -24,775,000USD |
| Income Tax Expense | 16,000USD | 58,000USD | — | — | — | 55,000USD | — | — |
| Tax Provision | 16,000USD | — | — | — | 0USD | — | — | — |
| Net Income | -40,368,000USD | -31,932,000USD | -25,175,000USD | -32,134,000USD | -2,518,000USD | -5,430,000USD | -16,277,000USD | -24,775,000USD |
| Net Income From Continuing Ops | -40,368,000USD | -31,932,000USD | -25,175,000USD | -32,134,000USD | -38,169,000USD | -30,112,000USD | -16,867,000USD | — |
| Ebit | -43,445,000USD | -34,979,000USD | -27,401,000USD | -32,134,000USD | -2,518,000USD | -5,375,000USD | -16,237,000USD | -24,775,000USD |
| Ebitda | -43,436,000USD | -34,970,000USD | -27,389,000USD | -27,778,000USD | -2,514,000USD | -5,367,000USD | -16,277,000USD | -24,747,000USD |
| Depreciation And Amortization | 9,000USD | 9,000USD | 12,000USD | 1,000USD | 4,000USD | 8,000USD | 218,000USD | 28,000USD |
| Reconciled Depreciation | 9,000USD | 9,000USD | 12,000USD | 5,000USD | 0USD | — | — | — |
| Total Other Income Expense Net | 3,093,000USD | 3,105,000USD | 2,226,000USD | -4,356,000USD | 869,000USD | 1,028,000USD | -1,312,000USD | 1,390,000USD |
| Unclassified Operating Expenses | — | — | — | — | -20,001,000USD | 2,456,000USD | — | 4,889,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | — | — | — | — | — |
| Cost Of Revenue | 26,000USD | 282,000USD | 96,000USD | 68,000USD | 15,000USD | 1,000USD |
| Gross Profit | -26,000USD | -282,000USD | -96,000USD | -68,000USD | -15,000USD | -1,000USD |
| Research Development | 93,121,000USD | 53,187,000USD | 64,218,999USD | 38,622,000USD | 14,987,000USD | 7,940,000USD |
| Selling General Administrative | 20,421,000USD | 8,608USD | — | — | — | — |
| Total Operating Expenses | 113,542,000USD | 74,314,000USD | 81,313,000USD | 53,169,000USD | 23,007,000USD | 8,888,000USD |
| Operating Income | -113,542,000USD | -74,596,000USD | -81,409,000USD | -53,237,000USD | -23,022,000USD | -8,889,000USD |
| Interest Income | 7,782,000USD | — | — | — | — | — |
| Net Interest Income | 7,782,000USD | — | — | — | — | — |
| Income Before Tax | -127,352,000USD | -69,573,000USD | -75,465,000USD | -51,486,000USD | -22,960,000USD | -9,611,000USD |
| Income Tax Expense | 58,000USD | 55,000USD | 56,000USD | 25,000USD | 3,000USD | — |
| Tax Provision | 58,000USD | — | — | — | — | — |
| Net Income | -127,410,000USD | -69,628,000USD | -75,521,000USD | -51,511,000USD | -22,963,000USD | -9,611,000USD |
| Net Income From Continuing Ops | -127,410,000USD | — | — | — | — | — |
| Ebit | -113,542,000USD | -69,573,000USD | -75,465,000USD | -51,486,000USD | -22,960,000USD | -9,536,000USD |
| Ebitda | -113,516,000USD | -69,291,000USD | -75,369,000USD | -51,418,000USD | -22,945,000USD | -9,535,000USD |
| Depreciation And Amortization | 26,000USD | 282,000USD | 96,000USD | 68,000USD | 15,000USD | 1,000USD |
| Reconciled Depreciation | 26,000USD | — | — | — | — | — |
| Total Other Income Expense Net | -13,810,000USD | 5,023,000USD | 5,944,000USD | 1,751,000USD | 62,000USD | -722,000USD |
| Unclassified Operating Expenses | — | 21,118,392USD | 17,094,001USD | 14,547,000USD | 8,020,000USD | — |
| Interest Expense | — | — | — | — | — | 75,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 319,433,000USD | 349,781,000USD | 202,450,000USD | 223,968,000USD | 77,533,000USD | 80,332,000USD | 90,959,000USD | 111,694,000USD |
| Other Current Assets | 7,222,000USD | 12,658,000USD | 2,455,000USD | 2,042,000USD | 1,163,000USD | 1,494,000USD | 1,875,000USD | 6,558,000USD |
| Total Liab | 22,971,000USD | 17,263,000USD | 23,104,000USD | 22,412,000USD | 2,487,000USD | 3,898,000USD | 10,466,000USD | 17,296,000USD |
| Total Stockholder Equity | 296,462,000USD | 332,518,000USD | 179,346,000USD | 201,556,000USD | 75,046,000USD | 76,434,000USD | 80,493,000USD | 94,398,000USD |
| Other Current Liab | 18,313,000USD | 14,388,000USD | 21,007,000USD | 14,034,000USD | 2,036,000USD | 3,187,000USD | 8,948,000USD | 12,366,000USD |
| Common Stock | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Capital Stock | 7,000USD | 7,000USD | 5,000USD | 5,000USD | — | — | 1,000USD | — |
| Retained Earnings | -214,757,000USD | -174,389,000USD | -142,457,000USD | -117,282,000USD | -235,570,000USD | -233,052,000USD | -227,622,000USD | -211,385,000USD |
| Cash | 55,085,000USD | 88,438,000USD | 50,106,000USD | 220,942,000USD | 44,220,000USD | 33,751,000USD | 31,115,000USD | 31,069,000USD |
| Cash And Short Term Investments | 311,295,000USD | 336,158,000USD | 198,905,000USD | 220,942,000USD | 76,210,000USD | 78,623,000USD | 88,730,000USD | 104,202,000USD |
| Total Current Assets | 318,517,000USD | 336,158,000USD | 201,360,000USD | 222,984,000USD | 77,373,000USD | 80,117,000USD | 90,605,000USD | 110,760,000USD |
| Total Current Liabilities | 22,292,000USD | 16,539,000USD | 22,357,000USD | 21,620,000USD | 2,417,000USD | 3,828,000USD | 10,315,000USD | 17,020,000USD |
| Net Debt | -54,406,000USD | -87,714,000USD | -49,359,000USD | -220,150,000USD | -43,908,000USD | -33,334,000USD | -30,575,000USD | -30,388,000USD |
| Short Long Term Debt Total | 679,000USD | 724,000USD | 747,000USD | 792,000USD | 312,000USD | 417,000USD | 540,000USD | 681,000USD |
| Short Term Investments | 256,209,999USD | 247,720,000USD | 148,799,000USD | — | 31,990,000USD | 44,872,000USD | 57,615,000USD | 73,133,000USD |
| Accounts Payable | 3,979,000USD | 2,151,000USD | 1,350,000USD | 7,586,000USD | 69,000USD | 224,000USD | 908,000USD | 4,179,000USD |
| Property Plant Equipment Net | 847,000USD | 896,000USD | 916,000USD | 924,000USD | 160,000USD | 215,000USD | 273,000USD | 853,000USD |
| Property Plant Equipment Gross | 847,000USD | 896,000USD | 916,000USD | 924,000USD | — | — | — | — |
| Accumulated Other Comprehensive Income | -342,000USD | 129,000USD | 29,000USD | -24,000USD | 50,000USD | 105,000USD | 224,000USD | -83,000USD |
| Common Stock Shares Outstanding | 57,777,165shares | 49,316,000shares | 39,584,489shares | 28,431,158shares | 828,143shares | 828,143shares | 3,155,547shares | 821,601shares |
| Non Current Assets Total | 915,999USD | 13,622,999USD | 1,090,000USD | 984,000USD | 159,999USD | 214,999USD | 353,999USD | 933,999USD |
| Non Current Liabilities Total | 678,999USD | 724,000USD | 747,000USD | 792,000USD | 70,000USD | 70,000USD | 150,999USD | 275,999USD |
| Non Currrent Assets Other | 68,999USD | 13,622,999USD | 174,000USD | 60,000USD | — | — | 80,999USD | 80,999USD |
| Net Working Capital | 296,225,000USD | 332,277,000USD | 179,003,000USD | 201,364,000USD | — | — | 78,704,000USD | — |
| Unclassified Equity | 511,549,000USD | 506,766,000USD | 321,766,000USD | 318,854,000USD | 310,563,000USD | 309,378,000USD | 307,887,000USD | 305,863,000USD |
| Unclassified Current Assets | — | -12,658,000USD | — | — | — | — | — | — |
| Short Term Debt | — | — | — | — | 312,000USD | 417,000USD | 459,000USD | 475,000USD |
| Long Term Debt | — | — | — | — | — | — | 96,700,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | -96,549,001USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 349,781,000USD | 80,332,000USD | 127,418,000USD | 135,301,000USD | 175,363,000USD | 4,715,000USD |
| Other Current Assets | 12,658,000USD | 1,494,000USD | 1,793,000USD | 2,276,000USD | 6,958,000USD | 103,000USD |
| Total Liab | 17,263,000USD | 3,898,000USD | 17,962,000USD | 8,558,000USD | 2,945,000USD | 1,774,000USD |
| Total Stockholder Equity | 332,518,000USD | 76,434,000USD | 109,456,000USD | 126,743,000USD | 172,418,000USD | 2,941,000USD |
| Other Current Liab | 14,388,000USD | 3,187,000USD | 14,821,000USD | 4,822,000USD | 1,150,000USD | 1,156,000USD |
| Common Stock | 5,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | — |
| Capital Stock | 7,000USD | 1,000USD | — | — | — | — |
| Retained Earnings | -174,389,000USD | -233,052,000USD | -163,424,000USD | -87,903,000USD | -36,392,000USD | -13,407,000USD |
| Cash | 88,438,000USD | 33,751,000USD | 23,491,000USD | 22,397,000USD | 54,197,000USD | 4,573,000USD |
| Cash And Short Term Investments | 336,158,000USD | 78,623,000USD | 122,439,000USD | 129,220,000USD | 167,375,000USD | 4,573,000USD |
| Total Current Assets | 336,158,000USD | 80,117,000USD | 124,232,000USD | 131,496,000USD | 174,333,000USD | 4,676,000USD |
| Total Current Liabilities | 16,539,000USD | 3,828,000USD | 17,637,000USD | 7,782,000USD | 2,550,000USD | 1,774,000USD |
| Net Debt | -87,714,000USD | -33,334,000USD | -22,816,000USD | -21,307,000USD | -53,623,000USD | -4,573,000USD |
| Short Long Term Debt Total | 724,000USD | 417,000USD | 675,000USD | 1,090,000USD | 574,000USD | — |
| Short Term Investments | 247,720,000USD | 44,872,000USD | 98,948,000USD | 106,823,000USD | 113,178,000USD | — |
| Accounts Payable | 2,151,000USD | 224,000USD | 2,396,000USD | 2,575,000USD | 1,208,000USD | 618,000USD |
| Property Plant Equipment Net | 896,000USD | 215,000USD | 902,000USD | 1,245,000USD | 728,000USD | 39,000USD |
| Property Plant Equipment Gross | 896,000USD | 0USD | — | — | — | — |
| Accumulated Other Comprehensive Income | 129,000USD | 105,000USD | 237,000USD | -466,000USD | -59,000USD | — |
| Common Stock Shares Outstanding | 31,359,958shares | 816,634shares | 752,332shares | 699,202shares | 697,439shares | 697,439shares |
| Non Current Assets Total | 13,622,999USD | 214,999USD | 3,186,000USD | 3,804,999USD | 1,030,000USD | 38,999USD |
| Non Current Liabilities Total | 724,000USD | 70,000USD | 324,999USD | 775,999USD | 395,000USD | — |
| Non Currrent Assets Other | 13,622,999USD | -211,855USD | 2,284,000USD | 2,559,999USD | 302,000USD | — |
| Net Working Capital | 332,277,000USD | 57,658,000USD | — | — | — | — |
| Unclassified Current Assets | -12,658,000USD | — | — | — | — | — |
| Unclassified Equity | 506,766,000USD | 309,377,000USD | 272,640,000USD | 215,110,000USD | 208,867,000USD | 16,348,000USD |
| Short Term Debt | — | 417,000USD | 420,000USD | 385,000USD | 192,000USD | — |
| Long Term Debt | — | 107,600,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | -107,530,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -40,368,000USD | -31,932,000USD | -25,175,000USD | -32,134,000USD | -38,169,000USD | -5,430,000USD | -16,277,000USD | -24,775,000USD |
| Depreciation | 9,000USD | 9,000USD | 12,000USD | 1,000USD | 0USD | 8,000USD | — | 28,000USD |
| Stock Based Compensation | 7,405,000USD | 9,396,000USD | 4,295,000USD | 3,895,000USD | 2,423,000USD | 1,229,000USD | 27,000USD | — |
| Other Non Cash Items | 6,938,000USD | 8,821,000USD | -191,000USD | -8,635,000USD | 15,408,000USD | 943,220USD | 42,428,000USD | 3,173,000USD |
| Change In Working Capital | 9,340,000USD | -10,538,000USD | -1,065,000USD | 4,233,000USD | 1,581,000USD | -6,568,220USD | 11,153,000USD | 1,141,000USD |
| Total Cash From Operating Activities | -24,081,000USD | -33,649,000USD | -22,124,000USD | -36,535,000USD | -18,757,000USD | -11,047,000USD | 37,304,000USD | -20,433,000USD |
| Capital Expenditures | 0USD | -3,000USD | -57,000USD | -136,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -24,081,000USD | -33,652,000USD | -22,181,000USD | -36,671,000USD | -18,757,000USD | -11,047,000USD | 37,304,000USD | -20,433,000USD |
| Investments | -8,470,000USD | -98,187,000USD | -148,708,000USD | — | 0USD | — | — | — |
| Total Cashflows From Investing Activities | -8,470,000USD | -98,162,000USD | -148,708,000USD | -12,986,000USD | — | 13,129,000USD | -26,833,000USD | 18,000,000USD |
| Total Cash From Financing Activities | -795,000USD | 170,160,000USD | 0USD | 190,608,000USD | -700,000USD | 554,000USD | 69,921,000USD | 24,380,000USD |
| Change In Cash | -33,353,000USD | -50,106,000USD | -170,836,000USD | 176,722,000USD | -19,457,000USD | 2,636,000USD | 46,000USD | 21,947,000USD |
| Begin Period Cash Flow | 88,438,000USD | 50,106,000USD | 220,942,000USD | 44,220,000USD | 87,970,000USD | 31,115,000USD | 31,069,000USD | 9,122,000USD |
| End Period Cash Flow | 55,085,000USD | 88,438,000USD | 50,106,000USD | 220,942,000USD | 44,220,000USD | 33,751,000USD | 31,115,000USD | 31,069,000USD |
| Other Cashflows From Financing Activities | -840,000USD | — | — | 156,000USD | — | — | -95,000,000USD | — |
| Unclassified Operating Cash Flow | -7,405,000USD | -9,405,000USD | — | -3,895,000USD | — | -1,229,000USD | — | — |
| Net Borrowings | — | 0USD | — | — | — | 0USD | 95,000,000USD | — |
| Issuance Of Capital Stock | — | -1,341,000USD | 0USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -98,159,000USD | -59,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | 98,187,000USD | — | -12,850,000USD | — | 13,129,000USD | -26,833,000USD | 18,000,000USD |
| Unclassified Financing Cash Flow | — | 171,501,000USD | — | 190,452,000USD | — | — | 69,921,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -127,410,000USD | -69,628,000USD | -75,521,000USD | -51,511,000USD | -22,963,000USD | -9,611,000USD |
| Depreciation | 26,000USD | 282,000USD | 96,000USD | 68,000USD | 15,000USD | 1,000USD |
| Stock Based Compensation | 20,009,000USD | 2,512USD | — | — | — | — |
| Other Non Cash Items | 40,917,999USD | 9,319,000USD | 8,849,000USD | 4,566,000USD | 2,059,000USD | 777,000USD |
| Change In Working Capital | -8,196,999USD | -11,169,000USD | 9,798,000USD | 7,755,000USD | -6,510,000USD | 974,000USD |
| Total Cash From Operating Activities | -94,689,000USD | -71,196,000USD | -56,778,000USD | -39,122,000USD | -27,399,000USD | -7,859,000USD |
| Capital Expenditures | -196,000USD | 0USD | -142,000USD | -195,000USD | -181,000USD | 0USD |
| Free Cash Flow | -94,885,000USD | -71,196,000USD | -56,920,000USD | -39,317,000USD | -27,580,000USD | -7,859,000USD |
| Investments | -246,779,000USD | — | — | — | — | — |
| Total Cashflows From Investing Activities | -247,006,000USD | 56,029,000USD | 11,876,000USD | 6,926,000USD | -113,434,000USD | — |
| Net Borrowings | 0USD | — | — | — | — | — |
| Total Cash From Financing Activities | 360,768,000USD | 25,427,000USD | 45,996,000USD | 396,000USD | 190,457,000USD | 8,918,000USD |
| Issuance Of Capital Stock | 189,111,000USD | — | — | — | — | — |
| Change In Cash | -33,751,000USD | 10,260,000USD | 1,094,000USD | -31,800,000USD | 49,624,000USD | 1,059,000USD |
| Begin Period Cash Flow | 33,751,000USD | 23,491,000USD | 22,397,000USD | 54,197,000USD | 4,573,000USD | 3,514,000USD |
| End Period Cash Flow | 88,438,000USD | 33,751,000USD | 23,491,000USD | 22,397,000USD | 54,197,000USD | 4,573,000USD |
| Other Cashflows From Investing Activities | -246,810,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | 156,000USD | 184,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | -20,035,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | 246,779,000USD | 56,029,000USD | 12,018,000USD | 7,121,000USD | -113,253,000USD | — |
| Unclassified Financing Cash Flow | 171,501,000USD | 25,243,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.